EC Approves First Treatment for SMA: Nusinersen (Spinraza) EC Approves First Treatment for SMA: Nusinersen (Spinraza)

The European Commission has granted marketing authorization for the first treatment for 5q spinal muscular atrophy in the European Union.International Approvals

Source: Medscape Medical News Headlines - June 1, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news